Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06428526 · ClinicalTrials.gov registry record · NA

Impact of Sensory Electrical Stimulation on Sensation and Tremor

A NA study of Essential Tremor and Healthy Individuals, sponsored by Shirley Ryan AbilityLab.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06428526: Active NA study of Essential Tremor and Healthy Individuals, sponsored by Shirley Ryan AbilityLab.

NCT06428526 is a NA study of Essential Tremor and Healthy Individuals that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 40 participants, below the 402-participant average among 41 other Essential Tremor trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06428526, a NA study of Essential Tremor and Healthy Individuals, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand the acute, short-term and long-term impact of transcutaneous and/or percutaneous electrical stimulation with afferent-specific electrical stimulation (asES) on proprioception and fine motor control in the upper extremity. For this purpose, the researchers will use transcutaneous and/or percutaneous asES, high-density electromyography (HD-EMG), arm kinematic measurements, and standardized clinical assessments. This study will be conducted in healthy able-bodied individuals and patients with essential tremor (ET).

Interventions

  • DEVICE Continuous stimulation strategy
  • DEVICE Closed-loop stimulation strategy

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-24
Est. Completion 2029-07-31
Phase NA
Shirley Ryan AbilityLab

138 total trials

What the registry record for NCT06428526 still lists

NCT06428526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 402-participant average among 41 other Essential Tremor trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Essential Tremor appearing as the primary indexed condition, and to 2 interventions - of which Continuous stimulation strategy is the first listed.

NCT06428526 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06428526 about?

NCT06428526 is a clinical study titled "Impact of Sensory Electrical Stimulation on Sensation and Tremor". The purpose of this study is to understand the acute, short-term and long-term impact of transcutaneous and/or percutaneous electrical stimulation with afferent-specific electrical stimulation (asES) on proprioception and fine motor control in the upper extremity. For this purpose, the researchers w...

What is the current status of trial NCT06428526?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-24. Estimated completion is 2029-07-31.

What conditions does trial NCT06428526 study?

This clinical trial studies the following conditions: Essential Tremor, Healthy Individuals.

What interventions are being tested in trial NCT06428526?

The interventions under investigation include: Continuous stimulation strategy (DEVICE), Closed-loop stimulation strategy (DEVICE).

Who is sponsoring clinical trial NCT06428526?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06428526 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Essential Tremor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06428526's enrollment target sits among peer trials

40 26th of 41 higher than 15 of 41 other Essential Tremor trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Essential Tremor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06428526, the US trial registry maintained by the National Library of Medicine. NCT06428526 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.